Priyanka Sharma, Ph.D. is the Co-Founder and Co-CEO of Kazmira Therapeutics, a company focused on advancing pharmaceutical-grade, THC-free cannabinoid medicine through science, quality, and regulated healthcare. She has helped build one of the first licensed 503A compounding pharmacies dedicated to CBD, leads the development of high-purity cannabinoid APIs, and works at the intersection of cannabinoid science, manufacturing, regulation, and clinical care. Dr. Sharma is a recognized thought leader on the future of cannabinoid medicine and has been featured by NPR, Yahoo Finance, MJBizDaily, Cannabis Business Times, and other industry publications.